Gabai Menivim Follow-up: What Really Changed After Series Y Was Redeemed

What This Follow-up Is Isolating

The main article already framed the core point: year-end 2025 was less a covenant story than a maturity-wall story. This follow-up isolates only the funding chain built around the redemption of Series Y. Not the broader property portfolio, not the residential-development pipeline, and not the fair-value story, but one narrower question: did January 2026 actually free the company, or did it simply replace one dependency with another.

It is easy to see why the company pushed for the transaction. As of December 31, 2025, current bond liabilities stood at NIS 416.2 million, and Series Y alone accounted for NIS 334.3 million of that amount. That was the pressure point. But this was not a covenant collapse. At the same date, equity stood at about NIS 445 million, the equity-to-adjusted-balance-sheet ratio was about 28%, and Series YD loan-to-collateral stood at about 60% versus an 80% ceiling.

In other words, January 2026 was not designed to rescue a company already brushing up against its covenant limits. It was designed to refinance a very large short-dated secured bond and to rearrange the collateral map. That distinction matters, because once that is the starting point, the question is not only whether the redemption was executed, but through which chain it was executed, who now holds the collateral, and where the new risk sits.

That chart largely explains on its own why redeeming Series Y was necessary. It also explains why the headline is not enough. The wall came down, but it did not leave the story. It was moved from the company level to the parent level, together with the collateral pool.

The New Chain: From Series Y to a Shareholder Loan

On November 24, 2025, the company’s board approved a conditional full early redemption of Series Y. The condition was the successful public issuance of a new Series B bond by Gabai Group. That parent-level series was meant to be secured by the same eight assets that had previously secured the company’s Series Y, plus one additional asset.

The condition precedent was satisfied on December 28, 2025, and the actual redemption was executed on January 8, 2026. As part of the early redemption, the company paid an early-redemption premium plus accrued interest totaling about NIS 1.8 million. Series Y holders got paid, and the series was delisted. From the perspective of the immediate problem, the wall was indeed removed.

But the mechanism matters more than the headline. When the redemption took place, a loan agreement with Gabai Group came into force. Under that agreement, the controlling shareholder extended a back-to-back shareholder loan to the company in an amount of about NIS 390 million, equal to the parent’s net issuance proceeds. The loan bears the same effective rate as Gabai Group’s Series B, which the company said was 5.43% to the best of its knowledge, and it follows the same amortization schedule: 3% of principal in 2026, 3% in 2027, 3% in 2028, and 91% in 2029.

That is the real shift. Until January 2026, the company owed the public directly through Series Y, secured by eight assets. From January 8, 2026 onward, it owes Gabai Group through an unsecured shareholder loan, while the public creditor holding the collateral is no longer the company’s Series Y holders but the parent’s Series B holders.

| Layer | Until January 8, 2026 | After January 8, 2026 | What it means | |-----|------|-------| | Main debt on the collateral pool | The company’s Series Y, with NIS 334.3 million classified as current at year-end 2025 | A shareholder loan of about NIS 390 million, back to back with Gabai Group’s Series B | The maturity wall was deferred, but the funding source moved up to the parent | | Core collateral | 8 assets pledged to Series Y holders | The same 8 assets, plus one additional asset, pledged to Gabai Group Series B holders | The collateral was not released. It moved up one layer in the structure | | Repayment profile | Series Y still had a heavy final maturity in 2026 | 3%, 3%, 3%, 91% across 2026 to 2029 | Near-term pressure fell, but a very large tail was created for 2029 | | Security behind the company loan | Not relevant | No collateral, no acceleration triggers, and the company may prepay early | There is theoretical flexibility for the company, but not actual freedom of the assets |

That table is the heart of the transaction. The company bought time, not freedom. It replaced direct public debt with debt to its controlling shareholder, but that debt is itself funded by a new public bond at the parent, using essentially the same asset base.

That chart makes clear why the January redemption does not end the story. Anyone focusing only on the disappearance of Series Y may conclude that the pressure is gone. In reality, the pressure simply changed shape: less of an immediate wall, more reliance on a structure that concentrates almost all principal at the far end.

What Public Creditors Gained, and What They Gave Up

Series Y holders got what they needed: full redemption, accrued interest, and the early-redemption increment. That is the immediate and obvious benefit of the move. The company’s remaining bond series also got some relief, because the largest current liability was removed without the company reporting any breach of financial covenants at year-end 2025.

But public creditors did not get a freed-up collateral pool. Quite the opposite. As of the report date, the same pool of assets that had previously supported the company’s Series Y was pledged to Gabai Group’s Series B holders, together with an additional asset in Bnei Brak. For the company’s other bondholders, especially the unsecured series, that is a material point: those assets did not become newly flexible at the company level. They simply moved from one secured creditor class to another, one level higher in the structure.

This is not a minor legal nuance. It is a shift in where the real leverage sits. Previously, the secured public creditor sat inside the company itself. Now the secured public creditor sits one floor above, through the parent’s indenture. In practical terms, the company is left with an unsecured shareholder loan that can be prepaid, but without free access to the asset pool that underpins the whole maneuver.

The execution mechanics make the same point. In Gabai Group’s January 8, 2026 immediate report, the parent said that after the trustee transferred the sums needed to repay the existing lenders and redeem Series Y, about NIS 24 million of the Series B proceeds would only be released to Gabai Group after the removal of existing liens, the amendment of mortgages and pledges in favor of Series B holders to first rank, insurance confirmations, and additional approvals. In other words, even after redemption day, not all of the parent’s issuance proceeds were immediately free. Part of the money remained contingent on the full completion of the collateral-transfer mechanics.

That fits with another disclosure in the annual report. In the period between December 31, 2025 and close to March 24, 2026, the company received NIS 362.5 million of long-term non-bank financing, and the footnote ties that amount to a loan from Gabai Group. Over the same period, the company repaid NIS 333.8 million of financing. In outcome terms, most of the money did not build a new liquidity buffer. It replaced old debt with new debt.

The net gap here is small relative to the size of the transaction, and that is exactly the point. January 2026 was not mainly a capital raise that created a large new liquidity surplus. It was primarily an exchange of one funding chain for another.

Why This Matters From Here

If January 2026 is read correctly, the conclusion is sharper than the headline suggests. This was not a move that proved the company had unlocked value from its assets. It was a move that showed the company could push out the immediate maturity wall by using the parent’s access to the capital markets, at the cost of deeper dependence on the controlling shareholder’s funding structure.

There is a real positive side here. The shareholder loan is unsecured, it has no acceleration triggers, and the company is allowed to prepay it early. If the next few years bring an asset sale, a cheaper refinancing, or some other funding outlet, that is flexibility the old Series Y structure did not necessarily provide in the same way.

But until that happens, the market should read the move more soberly. Series Y disappeared, yet the asset pool was not freed. Covenants were not on fire, yet funding dependence did not fall, it just moved to a different track. And the new amortization schedule looks very comfortable in the first three years, but it concentrates 91% of principal at the end. That is a deferral of the test, not a cancellation of it.

So the key question for 2026 to 2029 is not whether January solved 2026. It did. The question is whether, by 2029, the company will turn the time it bought into real flexibility: asset sales, stand-alone refinancing, lower leverage, or some other path that reduces dependence on a shareholder loan ultimately sourced from the parent’s public debt.

Conclusions

The redemption of Series Y on January 8, 2026 was the right and necessary move from a maturity-management perspective. It removed a current liability of NIS 334.3 million, paid out the holders, and stabilized the 2026 edge. But it was not an event that freed collateral or created surplus liquidity. It was a funding reorganization.

Current thesis in one line: January 2026 solved Gabai Menivim’s immediate Series Y maturity wall, but replaced it with deeper reliance on a back-to-back shareholder loan and on nine assets pledged to Gabai Group’s Series B holders.

What changed versus the earlier read? The center of risk moved. There is less fear around a near-term Series Y maturity, and more attention on who now holds the collateral, what the repayment path to 2029 looks like, and how much flexibility really remains inside the company itself.

The strongest counter-thesis is that the new structure is materially better than the old one: the company removed direct secured public debt from its own balance sheet, replaced it with an unsecured shareholder loan with no acceleration triggers, and gave itself a few relatively quiet years to refinance or monetize assets. That is a serious argument. The problem is that it only holds if the time bought in January is actually translated into a capital or asset move that reduces dependence on the parent’s funding chain.

What could change the market reading in the short to medium term? Mainly two things: progress on freeing up or refinancing assets already sitting deep inside the pledge structure, and evidence that the easier 2026-2028 schedule does not simply end in a larger 2029 snowball.

Why this matters: in leveraged real estate structures, the critical question is not only how much debt moved off the schedule, but on which floor the new debt now sits, who holds the collateral, and how much of the value is still truly accessible to the company itself.